Inventor
MARQUESS DANIEL
US61 patents
⚠️ This page may combine multiple inventors who share the name “MARQUESS DANIEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE INC
40 patentsUS6693202B1Feb 17, 2004
Muscarinic receptor antagonists
THERAVANCE INC253 citations99
US7655621B2Feb 2, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC26 citations96
US7649080B2Jan 19, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC24 citations96
US7601690B2Oct 13, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC25 citations96
US7375114B2May 20, 2008
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC41 citations96
US7341993B2Mar 11, 2008
Cross-linked glycopeptide—cephalosporin antibiotics
THERAVANCE INC22 citations96
US7279458B2Oct 9, 2007
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC50 citations96
US6974797B2Dec 13, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC45 citations96
US6878686B2Apr 12, 2005
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC49 citations96
US7067481B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC41 citations95
US8377964B2Feb 19, 2013
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations93
US7759363B2Jul 20, 2010
Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC18 citations93
US7728127B2Jun 1, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC20 citations93
US7612037B2Nov 3, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC18 citations93
US7592355B2Sep 22, 2009
Quinolinone-carboxamide compounds as 5-HT, receptor agonists
THERAVANCE INC13 citations93
US7553962B2Jun 30, 2009
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC21 citations93
US7317022B2Jan 8, 2008
Benzoimidazolone-carboxamide compounds as 5-HT4 receptors agonists
THERAVANCE INC19 citations93
US7763637B2Jul 27, 2010
Quinolinone-carboxamide compounds as 5-HT4, receptor agonists
THERAVANCE INC12 citations92
US7419989B2Sep 2, 2008
Indazole-carboxamide compounds
THERAVANCE INC19 citations92
US7399862B2Jul 15, 2008
5-HT4 receptor agonist compounds
THERAVANCE INC26 citations92
US7396933B2Jul 8, 2008
Quinolinone-carboxamide compounds
THERAVANCE INC28 citations92
US7351704B2Apr 1, 2008
Indazole-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC25 citations92
US7332471B2Feb 19, 2008
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC21 citations92
US7183323B2Feb 27, 2007
Sodium channel modulators
THERAVANCE INC20 citations92
US7067482B2Jun 27, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC43 citations92
US6995138B2Feb 7, 2006
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC34 citations92
US6756400B2Jun 29, 2004
Sodium channel modulators
THERAVANCE INC36 citations92
US6646012B2Nov 11, 2003
Sodium channel modulators
THERAVANCE INC30 citations92
US6479498B1Nov 12, 2002
Sodium channel drugs and uses
THERAVANCE INC36 citations92
US7728006B2Jun 1, 2010
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC11 citations84
US7534889B2May 19, 2009
5-HT4 receptor agonist compounds
THERAVANCE INC13 citations84
US7498442B2Mar 3, 2009
Quinolinone-carboxamide compounds
THERAVANCE INC10 citations84
US7446114B2Nov 4, 2008
Quinolinone compounds as 5-HT4 receptor agonists
THERAVANCE INC10 citations84
US7713931B2May 11, 2010
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC7 citations82
US7875629B2Jan 25, 2011
Quinolinone compounds as 5-HT4 receptor agonists
THERAVANCE INC6 citations74
US7405199B2Jul 29, 2008
Cross-linked glycopeptide-cephalosporin antibiotics
THERAVANCE INC5 citations73
US7226950B2Jun 5, 2007
Sodium channel modulators
THERAVANCE INC7 citations73
US6872741B2Mar 29, 2005
Sodium channel modulators
THERAVANCE INC7 citations73
US7772239B2Aug 10, 2010
Benzoimidazolone-carboxamide compounds as 5-HT4 receptor agonists
THERAVANCE INC4 citations63
US7329752B2Feb 12, 2008
Carbamate compounds as 5-HT4 receptor agonists
THERAVANCE INC4 citations63
MARQUESS DANIEL
4 patentsUS8575192B2Nov 5, 2013
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
MARQUESS DANIEL6 citations84
US8962653B2Feb 24, 2015
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
MARQUESS DANIEL5 citations83
US8163920B2Apr 24, 2012
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
MARQUESS DANIEL5 citations73
US9353106B2May 31, 2016
Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
MARQUESS DANIEL2 citations62
UNITY BIOTECHNOLOGY INC
2 patentsTHERAVANCE BIOPHARMA R&D IP LLC
2 patentsADVANCED MEDICINE INC
1 patentPRAXIS BIORESEARCH LLC
1 patentShowing the top 50 of 61 patents by PatentIndex Score.